Let’s start the week with another winner.
Just weeks ago, we recommended buying shares of Facebook (FB) at $158.25.
After an earnings beat, the stock is now up to $173.60. Take the win here, as the stock appears to be technically overbought.
As for new opportunities, take a look at Bristol Myers (BMY).
The stock plummeted on news that a rival cancer drug could perform better than the one it’s been working on. But what BMY has is just as incredible. Its Opdivo drug was found to redu...
Already a member? Login below, or click here to register now for free.